News

TORONTO, Jan 4 (LifeSiteNews.com) – Roberts Pharmaceutical Corporation, the US company which has begun marketing the abortifacient drug Preven in Canada, completed a merger with the British company Shire Pharmaceuticals Group in December. In anticipation of the expanded boycott LifeSite readers may wish to inform Shire that due to their involvement with Roberts, and thus the promotion and distribution of abortifacient drugs in Canada, they will be boycotted.

Rolf Stahel, Chief Executive
Shire Pharmaceuticals
East Anton, Andover Hampshire, SP10 5RG

Tel: +44 1264 348501
Email: [email protected]

For the boycott announcement against Roberts click here.